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Abstract
Background: The World Health Organization and European Centre for Disease Prevention and Control have highlighted the
importance of establishing systems to monitor severe influenza. Following the H1N1 (2009) influenza pandemic, a sentinel
network of 23 Trusts, the UK Severe Influenza Surveillance System (USISS), was established to monitor hospitalisations due
to confirmed seasonal influenza in England. This article presents the results of the first season of operation of USISS in 2010/
11.
Methodology/Principal Findings: A case was defined as a person hospitalised with confirmed influenza of any type. Weekly
aggregate numbers of hospitalised influenza cases, broken down by flu type and level of care, were submitted by
participating Trusts. Cases in 2010/11 were compared to cases during the 2009 pandemic in hospitals with available
surveillance data for both time periods (n = 19). An unexpected resurgence in seasonal A/H1N1 (2009) influenza activity in
England was observed in December 2010 with reports of severe disease. Reported cases over the period of 4 October 2010
to 13 February 2011 were mostly due to influenza A/H1N1 (2009). One thousand and seventy-one cases of influenza A/H1N1
(2009) occurred over this period compared to 409 at the same Trusts over the 2009/10 pandemic period (1 April 2009 to 6
January 2010). Median age of influenza A/H1N1 (2009) cases in 2010/11 was 35 years, compared with 20 years during the
pandemic (p =,0.0001).
Conclusions/Significance: The Health Protection Agency successfully established a sentinel surveillance system for severe
influenza in 2010/11, detecting a rise in influenza cases mirroring other surveillance indicators. The data indicate an upward
shift in the age-distribution of influenza A/H1N1 (2009) during the 2010/11 influenza season as compared to the 2009/10
pandemic. Systems to enable the ongoing surveillance of severe influenza will be a key component in understanding and
responding to the evolving epidemiology of influenza in the post-pandemic era.
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Introduction
The World Health Organisation and European Centre for
Disease Prevention and Control have highlighted the importance
of establishing surveillance systems to monitor the epidemiology of
severe influenza and severe acute respiratory disease [1,2]. The
UK Severe Influenza Surveillance System (USISS) is a web-based
scheme established in 2010/11, which collects surveillance data on
hospitalised influenza cases from a sentinel network of National
Health Service (NHS) Acute Trusts (usually comprising of one or a
group of hospitals) across England. The scheme aims to monitor
the impact of influenza on the population and describe the
epidemiology of severe influenza in time, place and person. Data
collected through USISS aims to assist in the evaluation and
development of clinical guidance as well as support the
development of policy, and has been instrumental in determining
the feasibility of a routine hospital surveillance system in England.
During the 2009 influenza pandemic, the UK experienced two
waves of activity, punctuated by the school summer holidays,
which affected primarily children and young adults. The second
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wave peaked in late October 2009 and declined by February 2010,
after which little influenza activity was observed until late 2010.
From early December 2010, the United Kingdom experienced a
sharp increase in influenza activity, peaking in late December and
then declining through January and into February 2011. Starting
in early December, the start of the season was heralded by a rapid
increase in reports of hospitalisations, intensive care admissions
and fatalities due primarily to influenza A/H1N1 (2009). There
was then a late, but rapid rise in primary care indicators: by week
49 (ending 12 December), rates of influenza-like illness (ILI)
general practitioner (GP) consultation, as measured by the Royal
College of General Practitioners (RCGP) Research and Surveil-
lance Centre Weekly Returns Service had crossed their baseline
value of 30/100,000 [3]. There continues to be uncertainty about
the reasons for this unexpected upsurge in severe cases.
During the 2009 pandemic, the Health Protection Agency
(HPA) and Department of Health (DH) in England ran a time-
limited web-based hospital surveillance system for confirmed
influenza cases in England (text S1) [4]. The scheme commenced
in September 2009 and ceased operation in January 2010. In this
paper, we present an analysis of data collected through the USISS
sentinel network on hospital admissions with confirmed influenza
in the 2010/11 season and compare the epidemiological picture to
that seen during the 2009/10 pandemic.
Methods
The USISS pilot scheme was established in October 2010 in
order to determine the feasibility, cost and resources required to
establish a routine hospital-based surveillance system for severe
seasonal influenza, and establish the infrastructure in advance of
any future pandemic. Voluntary enrolment of NHS Acute Trusts
in England in the scheme commenced in December 2010. A case
was defined as any person who was hospitalised and had a
laboratory confirmed influenza A (H1 or H3) or B infection.
Consultant microbiologists or infection control teams at each
participating sentinel Trust submitted a weekly aggregate report of
all cases admitted the previous week, broken down by influenza
type, age group and maximum level of care. In order to maximise
participation, enrolment in the scheme was not time-limited, with
trusts able to provide retrospective data from 4 October (week 40)
with their first data submission. A bi-weekly report was used to
disseminate data collected by USISS to stakeholders. In addition,
findings from USISS were shared on a regular basis with a wider
audience of clinical specialists from across the UK.
The dataset analysed here comprises data from 4 October 2010
(week 40) to 13 February 2011 (week 6) and was compared to data
from the pandemic period spanning 1 April 2009–6 January 2010.
The median age of cases from each time period was compared
using a Wilcoxon Rank Sum test. All statistical analysis was
performed using StataH (StataCorp Inc.) version 11.
Estimated influenza population hospitalisation rates were
calculated from 19 Trusts who submitted data during both the
2009 pandemic and the 2010–2011 influenza season. To calculate
the cumulative population age-specific hospitalisation rate the
number of hospitalised confirmed cases in each age group
admitted over each of these periods was divided by the total
population of England in the same age group (as the hospital
catchment populations were unknown). Although the time frames
for each period of influenza circulation were not identical in
length, they were taken to be equal for the purposes of this study,
since a seasonal (or annual) cumulative rate of hospitalisation was
being calculated. Population figures were the mid-year population
estimate for England in 2009 obtained from the Office for
National Statistics (ONS) [5]. The cumulative hospitalisation age-
specific rate ratio was calculated using the 2009–2010 pandemic
cumulative hospitalisation rate in each age group as the baseline.
Rate ratio confidence intervals were calculated as described by
Rothman KJ (1986) [6].
Data for the proportion of respiratory specimens submitted to
HPA and NHS laboratories positive by PCR for influenza A/
H1N1 (2009) by age group for the 2010–2011 influenza season (4
October 2010–14 February 2011) and pandemic period (20 April
2009–4 January 2010) were obtained from the HPA’s DataMart
system [7]. DataMart is a virological surveillance system that
extracts influenza PCR results (positive and negative) from a
network of 14 NHS and HPA laboratories across England. Chi2
tests were used to compare age-specific proportions of positive tests
between the pandemic period and the 2010–2011 influenza
season, as well as the proportion of cases admitted to critical care
during both time periods.
Ethical approval was not sought for this scheme as it is part of
routine national surveillance carried out under the NHS Act 2006
(section 251), which provides statutory support for disclosure of
such data by the National Health Service, and their processing by
the HPA, for the purposes of communicable disease control.
Results
A sentinel network of 23 of 168 (13.7%) Acute Trusts from
across England agreed to participate and submitted data to USISS
for the study period. Eight of the ten regions of England were
represented (North East England and the West Midlands were the
two regions not represented). Participating Trusts varied in size,
ranging from 316–1646 in-patient beds. All participating Trusts
had intensive care units and paediatric services.
Over the period from 4 October 2010 (week 40) to 13 February
2011 (week 6), a total of 1668 hospitalised cases of laboratory
confirmed influenza were reported by participating Trusts.
Admissions of cases, first reported in week 46 of 2010, started to
increase in week 48 of 2010, peaking in week 52 of 2010 (figure 1).
Case numbers declined steadily from week 1 of 2011 onwards,
reaching a plateau by week 6 2011. The timing of hospitalisation
of cases by week of admission resembled the rates of GP
consultation for ILI. Community ILI consultation rate, however,
increased starting in week 48 and peaked in week 51 (figure 1), one
week earlier than admissions of hospitalised cases. ILI GP
consultation rates then decreased and reached near-baseline levels
(,30/100 000) by week 4.
Of the 1668 reported cases, 1260 (75.5%) were due to influenza
A/H1N1 (2009), four (0.2%) were influenza A/H3N2, 49 (2.9%)
were influenza A/unknown subtype and 355 (21.3%) were
influenza B. The overall proportion of influenza B cases increased
over the season (figure 1). During week 52, at the peak of activity,
only 52 of 317 (16.4%) cases were influenza B; by week 3,
however, influenza B comprised 31 of 63 (49.2%) reported cases.
From week 3 to week 6, 66 of 127 (52.0%) reported cases were
influenza B.
Hospitalised cases occurred mainly in those under 65 years of
age. Amongst the 1668 cases, 304 (18.2%) were age 0–4 years, 90
(5.4%) were age 5–14 years, 733 (43.9%) were age 15–44 years,
390 (23.4%) were age 45–64 years and 151 (9.1%) were aged over
64 years (figure 2). The median age of hospitalised influenza A/
H1N1 (2009) cases at sentinel Trusts was 35 years (interquartile
range (IQR) 18–52). In contrast, during the pandemic period, the
median age of cases was 20 years (IQR 6–38) (p,0.0001). The
median age of influenza B cases was 26 years (IQR 17–44), with
their age distribution shown in table 1.
Severe Influenza Surveillance in England
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Based on data submissions from participating Trusts, the crude
overall cumulative hospitalisation rate at all sentinel Trusts (n = 23)
for influenza of all types for the period of week 40 2010–week 6
2011 was 3.2/100,000 general population. The hospitalisation rate
decreased with age, from 9.5/100,000 population for cases 0–4
years of age to 1.8/100,000 population for cases over 64 years.
In order to compare influenza hospitalisations during the 2010/
2011 season to hospitalisations during the 2009 pandemic, data
from 19 Trusts that participated in these severe disease
surveillance initiatives during both time periods was compared.
At these Trusts 1071 influenza A/H1N1 (2009) hospitalised cases
were reported during the 2010/11 season, compared to only 409
cases during the two 2009/10 pandemic waves (table 1). Both
during the pandemic and during the 2010/11 season, reports were
submitted both prospectively and retrospectively. Hospitalisation
rates were calculated from 19 Acute Trusts that submitted data
during both time periods. During the 2009 pandemic, the crude
overall rate of hospitalisation at these Trusts for influenza A/
H1N1 (2009), from 1 April 2009 to 6 January 2010, was 0.8/
100,000 population (table 1). During the 2010/2011 season, from
4 October 2010 to 13 February 2011, the crude overall rate of
hospitalisation for influenza A/H1N1 (2009) at the same Trusts
was 2.1/100,000 population. As in the pandemic, there was a
trend of decreasing hospitalisation rates with age, from 5.3/
Figure 1. Number of hospitalised cases of influenza by type and by week of admission with weekly Royal College of General
Practitioners (RCGP) influenza-like illness (ILI) consultation rate per 100 000 population: week 40 2010–week 6 2011, USISS
sentinel network (n=23), England.
doi:10.1371/journal.pone.0030279.g001
Figure 2. Number of hospitalised cases by age group and by week of admission: week 40 2010–week 6 2011, USISS sentinel
network (n=23), England.
doi:10.1371/journal.pone.0030279.g002
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100,000 population for cases 0–4 years to 1.1/100,000 population
for cases over 64 years. This compared to hospitalisation rates of
2.6/100,000 population for cases 0–4 years and 0.1/100,000
population for cases over 64 years during the 2009 pandemic.
Surprisingly, in 2010/2011, the lowest hospitalisation rate was
0.6/100,000 population in cases aged 5–14 years, a marked
difference from the pandemic period, when the hospitalisation rate
for this age group was the second highest, at 1.7/100,000
population.
Overall, all age groups were 2.6 times more likely to be
hospitalised with influenza A/H1N1 (2009) infection during the
2010/11 season than during the 2009 pandemic (confidence
interval 2.3 to 2.9). The rate ratio for hospitalisation increased
with age. The exception was those aged 5–14, who were
significantly less likely to be hospitalised than during the 2009
pandemic. The decrease in hospitalisation rates in cases 5–14
years during the 2010/11 season was corroborated by laboratory
data which showed that the proportion of positive influenza A/
H1N1 (2009) specimens for the 5–14 year age group decreased
from 43.3% during the pandemic to 17.6% in 2010/11
(p,0.0001) (table 2).
The crude overall rate of hospitalisation for influenza B from 4
October 2010 to 13 February 2011 in Acute Trusts that submitted
data both during the pandemic and in 2010/11, was 0.6/100,000
population. As observed for influenza A/H1N1 (2009), the rate of
hospitalisation decreased with age, from 2.0/100,000 population
for cases 0–4 years to 0.3/100,000 population for cases over 64
years.
Of 1668 hospitalised influenza patients, 1431 (85.8%) were
reported as admitted only to standard ward care (level 0, 1) and
237 (14.2%) to high dependency units ((HDU), level 2) or intensive
care units ((ICU), level 3). Two hundred and six (86.9%) of the
HDU/ICU admissions were influenza A/H1N1 (2009) cases, 11
were influenza A/unknown subtype and 20 were influenza B. The
peak of HDU/ICU admissions in 2010/11 occurred in week 52,
with 53 cases admitted comprising 22.4% of total HDU/ICU
influenza admissions in 2010/11. HDU/ICU admissions occurred
most frequently in 15–64 year olds, with 114 (48.1%) of 237
admissions in 15–44 year olds and 95 (40.1%) of 237 admissions
45–64 year olds.
Discussion
The HPA successfully established a sentinel surveillance system
for severe influenza, which demonstrated the impact and
epidemiology of severe influenza infection in a timely manner in
England in 2010/11. The system showed that during December
2010 to January 2011, there was a sharp rise in hospitalised cases
of confirmed influenza, which mirrored other indicators of
influenza activity. The majority of severe cases were due to
influenza A/H1N1 (2009) infection, with a minority due to
influenza B. As seen in previous years, the proportion of influenza
Table 1. Influenza hospitalisations and hospitalisation rates during the 2009 pandemic and during the 2010–11 influenza season,
and influenza A/H1N1 (2009) rate ratio of hospitalisation during the 2010–2011 influenza season compared to the 2009 pandemic,
USISS sentinel network (n = 19).
2009 Pandemic (1 April 2009–6
January 2010) 2010/11 influenza season (4 October 2010–13 February 2011)
Age Group
influenza A/
H1N1 (2009)
hospital
cases
Cumulative
hospitalisation
rate/100,000
population
Influenza
A/H1N1
hospital
cases
Cumulative
Hospitalisation
rate/100,000
population
Influenza A/H1N1
(2009) rate ratio of
hospitalisation
(95% CI)
Influenza B
hospital
cases
Influenza B
cumulative
hospitalisation rate/
100,000 population
0–4 82 2.6 169 5.3 2.1 (1.6–2.7) 63 2.0
5–14 101 1.7 36 0.6 0.4 (0.2–0.5) 41 0.7
15–44 162 0.8 496 2.3 3.1 (2.6–3.7) 117 0.6
45–64 53 0.4 275 2.1 5.2 (3.9–7.0) 44 0.3
65+ 11 0.1 95 1.1 8.6 (4.6–16.1) 29 0.3
Total 409 0.8 1071 2.1 2.6 (2.3–2.9) 294 0.6
doi:10.1371/journal.pone.0030279.t001
Table 2. Age-specific laboratory positivity rates for influenza during the 2009 pandemic and the 2010–2011 influenza season
reported by the DataMart laboratory surveillance system, England.
Influenza H1N1 (2009) proportion positive Influenza B proportion positive
Age group 2009 Pandemic 2010–2011 2010–2011
Total tests Positive tests (%) Total tests Positive tests (%) P-value Total tests Positive tests (%)
0–4 years 22616 2626 (11.6) 10979 1439 (13.1) ,0.0001 8495 459 (5.4)
5–14 years 14712 6376 (43.3) 2749 484 (17.6) ,0.0001 2192 535 (24.4)
15–44 years 35138 8506 (24.2) 13422 3968 (29.6) ,0.0001 9527 1167 (12.3)
$45 years 22683 2459 (10.8) 15236 2874 (18.9) ,0.0001 10893 645 (5.9)
All ages 95149 19967 (21.0) 42386 8765 (20.7) 0.20 31107 2806 (9.0)
doi:10.1371/journal.pone.0030279.t002
Severe Influenza Surveillance in England
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B cases increased with time over the 2010/11 season. Rates of
severe disease were higher than observed in the 2009/10
pandemic. The data indicates an increase with age in the risk of
hospitalisation as well as a shift in the age-distribution of severe
influenza A/H1N1 (2009) cases away from the 5–14 year age
group, which had the highest attack rate during the 2009/10
pandemic, to older age groups during the 2010/11 seasonal
influenza season. A significant number of influenza B cases
occurred in 15–44 year olds; however the highest rates of
hospitalisation for influenza B were in 0–4 year olds, followed by
5–14 year olds.
Although this study provides an estimate of the burden of severe
influenza during the 2010/11 season, there are several limitations
to these data. Firstly data analysis was limited by the lack of
individual-level data on underlying risk factors for severe disease,
course of illness, mortality outcome and antiviral use, restricting
the ability to monitor epidemiological changes in the population
vulnerable to severe disease and linkage with other records to
assess the influence of vaccination status or clinical history.
Secondly since aggregate data reporting is less time consuming
than individual level data reporting, it is possible that the overall
increase in cases observed in 2010/11 was partially due to more
complete case reporting than during the 2009 pandemic, when
individual-level data was reported. Thirdly, in contrast to during
the pandemic, when 129 of 168 (77%) Trusts participated in
surveillance (text S1) [4], USISS was developed as a sentinel
scheme, with participation of 23 of 168 (13.7%) of Trusts. Hence
the comparative analysis has been restricted to the same 19 trusts
in both periods. As a result, although the hospitalisation rates
reported here provide for meaningful comparisons of age-specific
rates between different time periods, they are lower than the true
hospitalisation rates since the denominator is the total population
of England.
The findings are corroborated by other influenza activity
indicators. These are helpful in addressing potential confounding
due to changes in health care seeking behaviour or criteria for
hospitalisation between the two time periods, which were difficult
to measure directly. Community indicators, such as general
practitioner influenza-like illness consultations rates, and syndro-
mic surveillance indicators, such as telephone calls to the
telephone help-line, NHS Direct, both indicated high levels of
activity in 2010/11 [8,9]. RCGP GP consultation rates continued
to rise and reached a peak of 124.4/100,000 in week 51, the
highest rate seen in 10 years apart from during the summer of the
2009 pandemic [8]. A similar trend was seen with various other
syndromic surveillance indicators, with cold/flu calls to the
telephone health advice service, NHS Direct, peaking in week
51 [8]. In addition to high levels of influenza in primary care and
the community, there was also a sharp increase in severe influenza
cases. By week 1, 783 critical care beds (22.5%) in England were
occupied by suspected or confirmed influenza patients [10], with
particular pressure on Extra Corporeal Membrane Oxygenation
(ECMO) facilities across England. Although some widespread
influenza activity with possible localised hotspots had been
expected due to the H1N1 (2009) virus during the 2010–2011
influenza season, the abrupt increase in activity across the UK this
season was surprising. Following the decline of influenza activity at
the end of the second wave in 2010, serological studies undertaken
in February 2010 had indicated that there was substantial
immunity in the population to the pandemic H1N1 strain,
particularly in younger age-groups [11]. The influenza A/H1N1
(2009) activity that began in December 2010 occurred despite
virological analyses indicating that there was no significant
antigenic change in the strain since 2009/10 [12]. Overall,
however, there was an increase with age in the risk of being
hospitalised compared to 2009, expressed as the risk per head of
population, despite a considerable proportion of the population at
risk of severe disease having been immunised against A/H1N1
(2009). As in 2009, H1N1 (2009) cases aged 0–4 years in 2010/11
were the most likely to be hospitalised. This is corroborated by
other data, such as GP consultation rates and age-specific
laboratory positivity rates; however it is possible that there was a
behavioural component to this finding. Rates of hospitalisation
were also elevated in the 15–64 year age-group, with those 64
years and older the least likely to be hospitalised. There was,
however, a marked decrease in the influenza A/H1N1 (2009)
hospitalisation rate for the 5–14 year age-group in 2010/11
compared with 2009/10. This was the age group with the highest
age-specific positivity in the virological surveillance schemes in
2009/10 (table 2), while during 2010/11, the highest positivity
observed in the 15–44 and over $45 year age-groups. Thus,
despite being the group most affected during the pandemic, likely
due to lack of prior immunity and increased risk of exposure,
influenza A/H1N1 (2009) transmission seems to have shifted from
the 5–14 age-group to older age-groups in 2010/11, as a result of
an increase in immunity in children and young adolescents. It has
previously been shown that the risk of influenza-related ICU
admissions and fatalities increases with age [13]. Older age groups
are more likely than children to develop severe influenza requiring
hospitalisation and critical care due to a higher prevalence of
underlying clinical risk factors, which may partly explain the
observed increase in impact (text S1) [4]. Another potential
contributory factor for the apparent increase in severity compared
to the 2009/10 pandemic may have been an increase in bacterial
co-infections in influenza A/H1N1 (2009) cases [14]. The
proportion of H1N1 (2009) cases in HDU/ICU was significantly
higher in 2010/11 than during the pandemic, when 253 of 2416
(10.5%) of cases were admitted into HDU or ICU (p=,0.0001)
(text S1) [4].
A shift in the incidence of both uncomplicated and severe
influenza to older age groups as well as an increase in severe
influenza activity was also seen in several other European
countries in 2010/11. In Greece, 2010/11 ILI rates were higher
than in previous seasons (apart from the 2009 pandemic), with an
increase in the median age of sentinel ILI cases compared to the
2009 pandemic. An increase in both influenza-related ICU
admissions and fatalities was noted in 2010/11 compared to the
2009 pandemic, with older age groups affected in 2010/11 [15].
In Ireland, ILI rates in the 0–15 year age-group were significantly
lower in 2010/11 than during the 2009 pandemic [16]. This
phenomenon has been associated not only with the 2009
pandemic, but also with previous pandemics, such as those seen
in 1918, 1957 and 1968 [17,18].
This study shows evidence of an overall increase with age in
the risk of hospitalisation compared to the 2009/10 pandemic
period, as well as a shift in age distribution for severe influenza
infection during the 2010–2011 influenza season. This demon-
strates the benefit of hospital surveillance in rapidly determining
which groups (e.g. age or with underlying health conditions) are
at risk of developing severe disease and its potential for providing
early warning of atypical patterns of severe acute respiratory
illness presenting to hospital. Furthermore through weekly
submissions from Acute Trusts, data obtained through the
USISS pilot has the ability to provide a timely indication of
changes in the epidemiology of severe influenza, and thus
potentially contribute to the refinement of clinical care guidelines
and support of policy.
Severe Influenza Surveillance in England
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